Objective. Early childhood is a time of rapid development, particularly of the central nervous system, and can set a foundation for the entire life course. Complex pain in young children can impact the quality of life through limiting physical and social development, compromising psychological wellbeing, and disrupting sleep. The aim of this review is to identify the needs of young children who present to a tertiary-level pain service, what services they require, and their treatment outcomes. There are limited data on this vulnerable population, which may be due to small numbers represented and the complexities of pain assessment in this age group.
Introduction
Early childhood is defined as the period from prenatal development to eight years of age [1] . It is considered to be the most important developmental phase in life as it is marked by rapid development of the central nervous system. What happens in a child's early years sets a foundation for the entire life course. There is evidence that high levels of stress hormones that may be caused by persistent pain can disrupt the developing brain's architecture, overwhelming the plasticity of the infant brain. This is particularly important in setting a foundation for learning later in life as well as future behavior and health outcomes [2] .
Chronic pain is typically recognized as pain that has persisted past the normal time of healing, usually three months. Pediatric clinicians, however, tend to define pain in terms of its quality and mechanism rather than its duration [3] . Many prefer to use the terms "persisting pain" or "complex pain," which is the term used in this paper. Children with complex pain require a treatment paradigm that specifically incorporates physical, developmental, social, and psychological factors. This mandates a multidisciplinary approach [3] . Complex pain in young children potentially impacts quality of life through limitation in physical and social development, compromised psychological well-being, and sleep disruption [4, 5] . Pain's impact on cognition, concentration, and motor function has been well demonstrated and may impair learning [6] . While childhood complex pain can clearly impact development, conversely, it may also be a reflection of an underlying developmental vulnerability [6] .
Most epidemiological surveys of complex pain in children have been conducted in community settings, and a broad range of prevalence rates have been reported [7] . Prevalence estimates generally indicate a higher rate of complex pain in females and an increasing prevalence of most pain types with age [7] [8] [9] . Of note, the sex distribution is reversed in infants 0-3 years of age [8] and in preterm boys who show more adverse neurodevelopmental outcomes than girls [6] . While a vast majority if children cope with their pain independently or with their primary care provider, a small proportion (5%) of children reporting persisting pain are referred to specialized pediatric pain clinic services [10] .
The Complex Pain Clinic at The Children's Hospital at Westmead, Australia, is a tertiary referral center for New South Wales delivering care through multidisciplinary assessment and management, a day program, and telehealth. Children receiving care through this clinic have access to multidisciplinary care from medical, nursing, psychology, and physiotherapy clinicians. The initial visit is always with a medical pain specialist and a nurse, with the level of multidisciplinary care being determined on triage, which, however, can be altered at any stage in their care. All children are provided with a written pain management plan. The clinic functions primarily as a consultative service to support local primary care clinicians to enhance local accessible care, and it also provides direct care through a day program. The pharmacological management of the children is based on World Health Organization guidelines [4] .
There is little literature describing the presentation and outcomes of young children referred to a pediatric complex pain clinic. This study describes our experience caring for such young children.
Methods
After HREC approval as a quality improvement project, a retrospective chart review of all children younger than eight years of age who were referred to the Complex Pain Clinic at the Children's Hospital at Westmead (CHW), Sydney, between 2012 and 2014 was completed. The review systematically documented information on demographics, gender, pain location and etiology, treatment, and outcomes from both electronic and paper records.
Descriptive statistics were used to analyze the data collected.
Results

Demographics
Of the 335 children referred over three years, a majority were adolescents, and 28 (8.3%) were younger than eight years of age. Sixty-eight percent (19) of these were female, and 32% (nine) male. Ten were younger than five years of age. Four of the six infants younger than age three years were boys.
Pain Location and Duration
Lower limb pain was the commonest presentation (11 of the 28 cases), followed by abdominal pain (four), hip (two), headache (two), back (two), facial (one), and upper limb pain (one). One patient had multifocal pain due to inflammatory arthritis, and three patients had total body sensitivity. Two of these patients' pain was related to oncological disease, and one child had a transverse myelitis. One patient presented with irritability that was likely pain-related but without an identified location and was managed by the palliative care service. The duration of pain at the time of presentation to the Complex Pain Clinic ranged from just under one month to 4.5 years.
Etiology and Mechanism of Pain
The etiology of the pain in these young children included a defined disease process (19), persistent postoperative pain (six), previous trauma (two), and complex regional pain syndrome (one).
An identifiable mechanism or disease process was evident in all but two of the 28 young children and included persisting postoperative neuropathic pain following multilevel surgery (seven), neuropathic pain following treatment for cancer (four), inflammatory joint pain (five), and two children with suspected visceral pain. Importantly, six of the children were developmentally delayed. Five of these were wheelchair bound. In all cases, parent/caregiver report and observation were central to the assessment and management plan.
Outcomes
Eleven children of the cohort of 28 were successfully treated and discharged pain-free. Resolution of pain occurred within two months for all these cases. Among these children were seven with persistent postoperative pain, two with inflammatory joint disease, and one each with headaches and abdominal pain. Seven children had pain that persisted beyond two months and required multidisciplinary management for up to two years. Two patients had intractable pain-a seven-yearold child with abdominal pain of unknown etiology (managed for 4.5 years) who was reluctant to engage in nonpharmacological or psychological therapies and a five-year-old with abdominal pain secondary to a short gut syndrome. Two children were lost to follow-up, and six children were transitioned to other services (palliative care, psychological medicine, and rehabilitation medicine) with ongoing pain and complex medical issues.
Demand on Pain Clinic Resources
The number of face-to-face clinic visits and telephone consultations was documented and demonstrated that a large amount of care is delivered by telephone. Seventeen patients required only one clinic visit, 10
Complex Pain in Young Children required two to three clinic visits, and only one patient required more than three face-to-face visits.
On the other hand, 103 phone consultations were required by the cohort. The median number was four per child (range ¼ 1-17). The three most intensive cases required an average of 13 phone calls and were seen face to face a total of eight times.
School Loss, Sleep Disruption, and Disability
A search for pain-related morbidity revealed that sleep disruption (13 children) and anxiety (five children) were common. School absenteeism was surprisingly less common (three of 18 school-age children). All parents felt they were well supported by their school and did not require a school pain management plan. Depression was diagnosed in one child age seven years whose pain was undiagnosed and who was referred to psychological medicine.
Therapeutic Modalities
Most initial consultations were held with a medical pain specialist, nurse practitioner, clinical psychologist, and physiotherapist. Psychiatry input is available on an asneeded basis. Nine children received psychological input from a psychologist or psychiatrist in hospital or in the community. All children are provided with a written pain management plan.
Management plans emphasize daily routine (especially bedtime routine) and relaxation strategies. Parental anxiety is also addressed as it can alter treatment direction and assessment of the child [5] .
Physical therapies remained central to therapy. Six children were formally referred to physiotherapists for both land and hydrotherapy. Parents were specifically educated on graduating and pacing physical activity as this was often challenging for younger children.
A number of parent and child education resources were used to complement the nonpharmacological strategies. These included books, applications, websites, and distraction strategies. The high compliance rate to therapies may be attributed to the dominant role of a caregiver in the lives of young children.
Pharmacological Interventions
Of the 28 children, only six were prescribed opioids (morphine, oxycodone, tramadol, codeine, or fentanyl). Three of these were pediatric palliative care patients, and these patients remained on regular dose opioids. The other three patients (suffering paroxysmal extreme pain disorder, intermittent back pain, and intermittent joint dislocations) were prescribed opioids pro re nata. All opioid use was monitored regularly via telephone and clinic review, and prescription was limited to one prescriber. Antineuropathic agents were prescribed to 14 children (gabapentin in 10 children and amitriptyline in four). Only one child required both an opioid and an antineuropathic agent. Five children were managed with simple analgesics (ibuprofen or paracetamol) alone. Three avoided all pharmacological interventions. Analgesic adjuncts, including diazepam for spasmodic pain in one child and melatonin in two children, were managed by primary treating teams.
Discussion
As a percentage of the Complex Pain Clinic population overall, young children represented only a small group (8.3%), and preschool children an even smaller subset (3%). Given the potentially devastating impact of persisting pain on the development of young children and the lack of evidence-based approaches to treatment in the literature, this clinic population represents a particularly vulnerable group.
The lack of literature likely reflects the relatively low prevalence of the problem and therefore limited single-center caseloads. Further reasons include the complexity of pain assessment in young children. While the assessment of young children with complex pain should remain within a biopsychosocial model [11] , the outcomes of this study prompt a more nuanced approach. First, all children but two had an obvious physical pathology explaining their pain. While persisting postoperative pain and pain secondary to cancer chemotherapy were common, the majority of cases belonged to a broad heterogeneous range of conditions. Most of these were rare, tertiary-level pediatric conditions requiring specialist expertise in disease-modifying strategies.
This study of young children with complex pain highlighted the dependence of clinicians on caregivers' reports. Management plans were regularly based on caregivers' observations of behaviors and their reports of treatment responses. This is entirely consistent with the fact that the ability for children to give self-report is still evolving between the ages of three to seven [3] . An understanding of the child's social and cultural context is essential when dealing with complex pain in young children as expression of pain and responses to treatment are always interpreted through a caregiver's report of normal baseline and behavioral responses [5, 11, 12] . While caregivers have personal ways of recognizing and responding to their child's pain, they may also experience uncertainty in their judgments [13] . It is important that the assessment process is sensitive to caregivers attitudes, which can range from catastrophizing to a lack of awareness. Clues can often be gained through sensitive questioning about schooling, sleep, and activity levels.
Validated acute pain assessment tools in pediatrics, such as the Crying, Requires O2, Increased vital signs, Expression, Sleepless, Face, Legs, Activity, Cry, Consolability (FLACC), revised FLACC, and FACES scales, are commonly utilized; however, the appropriateness of these scales in the setting of persisting pain is unclear [14] .
Pharmacological intervention in our cohort of young children played a secondary role to physical therapies. Antineuropathic agents and simple analgesics allowed the relatively restricted use of opioids. Despite the lack of an evidence base for most pediatric drug therapies [16] , decisions on drug therapies are generally made on a presumed pain mechanism, on adult data when available, and on empirical knowledge [15] . The majority of children had a presumed neuropathic basis for persisting pain either as a complication of multilevel surgery or as a complication of cancer chemotherapy. Gabapentin and pregabalin are commonly prescribed medicines for the treatment of neuropathic pain; however, no RCTs have been performed in children. A Cochrane review of pain-related functional gastrointestinal disorders in children failed to support the use of tricyclic antidepressants for pain in the pediatric population [16] .
Approximately 20% of children in our cohort were prescribed an opioid for varying periods of time without major adverse effects. This confirms a small but feasible role for opioids in the treatment of severe nonmalignant pain in the context of a pediatric multidisciplinary pain clinic [15, 17] . In our experience, the primary role for opioids in pediatric complex pain is to aid physical therapies or to help manage severe flare-ups of complex conditions. We have therefore found little need for ongoing opioid therapy [15] . Prescription of analgesics in young children necessitates the construction of a safe system of prescription and administration. In our practice, this includes written information on the analgesic, appropriate drug formulations, safe storage arrangements, close monitoring of efficacy and side effects, regular review, and, in the case of opioid prescriptions, a single prescriber.
As there is very little literature on young children's pain, further studies are needed, particularly in the areas of children's developmental processes in perceiving and responding to pain that could inform future treatment approaches and increase understanding of age differences in pain prevalence across the lifespan [5, 7] . Future research would be helpful in identifying temperamental and attachment patterns in early childhood, along with parental influences on early emotional development of children with complex pain [5] .
This review has a number of limitations, including its retrospective nature and its small patient cohort from a single center. Our review clearly included only those children treated in a complex pain clinic and therefore does not capture children whose pain is managed by nonspecialist clinicians or primary care providers.
Conclusion
Young children with complex pain form a small but vulnerable group of patients whose long-term outcomes are unknown. The potential for persisting and adverse effects on the physical, social, psychological, and educational well-being of these children is large [2] . Our findings are consistent with the small amount of available literature on young children with persisting pain. Successful management is based on identifying underlying pain mechanisms, close attention to caregiver reports and attitudes, physical therapies, and judicious use of pharmacological interventions.
